Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01041794 · ClinicalTrials.gov registry record

Tissue Partitioning in Early Childhood

A clinical trial, sponsored by University of Alabama at Birmingham.

Completed
Registry status
24
Enrollment target

NCT01041794 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01041794 has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
24 participants
Enrollment target

Study Summary

Early childhood (\~4-6 years of age) is an important window for determining body composition trajectory and may be a critical period for the development of tissue partitioning patterns that influence later disease risk, including obesity and type 2 diabetes. As adiposity accelerates during this critical period, deposition/ preservation of fat stores may be sustained at the 'expense' of other tissues; i.e. energy homeostasis may be inherently biased toward fat gain. The type and amount of tissue mass accrued in early childhood has implications for metabolic profile, glucose/insulin homeostasis, hormone profile and resting energy expenditure. The interplay between fat and bone deposition represents a physiologic trait enabling the body to choose between shuttling 'energy' towards accrual of a particular tissue. Plausibly the phenotype underlying obesity and diabetes risk may be determined by the differentiation of cell type (adipocyte, osteocyte, etc.) during this early stage of growth and development. In vitro studies demonstrate transdifferentiation under the influence of specific external stimuli, which can switch phenotypes toward other cell lineages. Further, rodent models have demonstrated that exposure to stimuli (exercise) early in life may prevent excess fat mass accrual in adulthood, even when the stimulus is later removed (animals are no longer exercising). Children's early experiences (engagement in physical activity) may 'environmentally induce' alterations in body composition and predispose individuals to diabetes throughout life (Figure 1). Hypotheses and Specific Aims: Early growth patterns and cell differentiation may induce long term effects on body composition by impacting biological and hormonal axes that regulate childhood body composition. Body composition comprises not only absolute mass, but also aspects of size, shape and location. To that end, the following specific aims will be evaluated: 1. Quantify body composition, adipose tissue distr

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2009-12
Est. Completion 2011-06

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT01041794

The ClinicalTrials.gov registry entry for NCT01041794 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01041794 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01041794 about?

NCT01041794 is a clinical study titled "Tissue Partitioning in Early Childhood". Early childhood (\~4-6 years of age) is an important window for determining body composition trajectory and may be a critical period for the development of tissue partitioning patterns that influence later disease risk, including obesity and type 2 diabetes. As adiposity accelerates during this crit...

What is the current status of trial NCT01041794?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2009-12. Estimated completion is 2011-06.

Who is sponsoring clinical trial NCT01041794?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.